These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17207722

  • 1. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung E, Menon S, Nallamothu BK, Chan PS.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):50-8. PubMed ID: 17207722
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T, Kereiakes DJ, Onufer J, Woelfel A, Gursoy S, Peterson BJ, Brown ML, Pu W, Benditt DG, MASTER Trial Investigators.
    J Am Coll Cardiol; 2008 Nov 11; 52(20):1607-15. PubMed ID: 18992649
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T, Saghir S, Bartone C, Goebel M, Schneider J, Booth T, Chan PS.
    Am J Cardiol; 2007 Aug 15; 100(4):598-604. PubMed ID: 17697813
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of microvolt T-wave alternans to predict outcomes in patients with ischemic cardiomyopathy beyond one year.
    Chan PS, Kereiakes DJ, Bartone C, Chow T.
    Am J Cardiol; 2008 Aug 01; 102(3):280-4. PubMed ID: 18638586
    [Abstract] [Full Text] [Related]

  • 6. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O, Hohnloser SH, Kirk MM, Lerman BB, Baker JH, Sethuraman B, Dettmer MM, Rosenbaum DS, ABCD Trial Investigators.
    J Am Coll Cardiol; 2009 Feb 10; 53(6):471-9. PubMed ID: 19195603
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):112-21. PubMed ID: 16814657
    [Abstract] [Full Text] [Related]

  • 8. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M, Salerno-Uriarte D, Guzzetti D, Rossi MC, Zoli L, Forzani T, Salerno-Uriarte JA.
    Int J Cardiol; 2005 Oct 20; 105(1):53-7. PubMed ID: 16207545
    [Abstract] [Full Text] [Related]

  • 9. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal.
    Chan PS, Bartone C, Booth T, Kereiakes D, Chow T.
    Am Heart J; 2007 Apr 20; 153(4):523-9. PubMed ID: 17383288
    [Abstract] [Full Text] [Related]

  • 10. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, Davidenko JM, Shinn TS, Fontaine JM.
    J Am Coll Cardiol; 2006 Jan 17; 47(2):456-63. PubMed ID: 16412877
    [Abstract] [Full Text] [Related]

  • 11. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R, Michałkiewicz D, Cholewa M, Jacewicz K, Gniłka A, Adamus J.
    Pol Merkur Lekarski; 2006 Oct 17; 21(124):310-3. PubMed ID: 17205766
    [Abstract] [Full Text] [Related]

  • 12. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B, Kowalczyk J, Lenarczyk R, Kowalski O, Sędkowska A, Cebula S, Musialik-Łydka A, Kalarus Z.
    Kardiol Pol; 2012 Oct 17; 70(5):447-55. PubMed ID: 22623232
    [Abstract] [Full Text] [Related]

  • 13. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB, Xie X, van der Avoort CJ, Dendukuri N, Brophy JM.
    Int J Technol Assess Health Care; 2009 Apr 17; 25(2):151-60. PubMed ID: 19331707
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction.
    Chan PS, Chow T, Kereiakes D, Schloss EJ, Waller T, Eagle K, Hayward RA, Vijan S.
    Arch Intern Med; 2006 Nov 13; 166(20):2228-33. PubMed ID: 17101941
    [Abstract] [Full Text] [Related]

  • 15. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum.
    Bloomfield DM, Steinman RC, Namerow PB, Parides M, Davidenko J, Kaufman ES, Shinn T, Curtis A, Fontaine J, Holmes D, Russo A, Tang C, Bigger JT.
    Circulation; 2004 Oct 05; 110(14):1885-9. PubMed ID: 15451804
    [Abstract] [Full Text] [Related]

  • 16. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
    Cantillon DJ, Stein KM, Markowitz SM, Mittal S, Shah BK, Morin DP, Zacks ES, Janik M, Ageno S, Mauer AC, Lerman BB, Iwai S.
    J Am Coll Cardiol; 2007 Jul 10; 50(2):166-73. PubMed ID: 17616302
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhancing specificity without sacrificing sensitivity: potential benefits of using microvolt T-wave alternans testing to risk stratify the MADIT-II population.
    Cohen RJ.
    Card Electrophysiol Rev; 2003 Dec 10; 7(4):438-42. PubMed ID: 15071271
    [Abstract] [Full Text] [Related]

  • 19. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
    Armoundas AA, Hohnloser SH, Ikeda T, Cohen RJ.
    Nat Clin Pract Cardiovasc Med; 2005 Oct 10; 2(10):522-8. PubMed ID: 16186850
    [Abstract] [Full Text] [Related]

  • 20. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ, Bigger JT.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1399-404. PubMed ID: 17010802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.